Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven R Feldman

Showing results (371-380 of 1,293) with videos related to

Pageof 130
Sort By:
Cureus|February 27, 2023
Treatment Adherence in Dermatology During the COVID-19 Pandemic: A ReviewSarah G Bridgeman, Patrick O Perche, Steven R Feldman
Archives of Dermatological Research|January 4, 2025
Bridging the gap in early diagnosis of hidradenitis suppurativaNatalia V Chalupczak, Katie K Lovell, Steven R Feldman
Expert Review of Clinical Immunology|June 22, 2016
Current status and future prospects for biologic treatments of psoriasisAbigail Cline, Dane Hill, Robin Lewallen, et al.
The Journal of Dermatological Treatment|June 9, 2024
Racial differences in access to psoriasis biologicsShirley P Parraga, Alan B Fleischer, Steven R Feldman
The Journal of Dermatological Treatment|July 23, 2024
Utilizing artificial intelligence technology with emotional intelligence in clinical office visitsRobin C Yi, Hannah Y Gantz, Steven R Feldman
The Journal of Dermatological Treatment|October 20, 2021
The relative weak way and the absolute strong way to communicate risk informationPatrick O Perche, Madison K Cook, Steven R Feldman
Expert Opinion on Drug Metabolism & Toxicology|September 11, 2023
JAK1 inhibitors for the treatment of atopic dermatitis: a focus on pharmacokinetic considerationsHannah Kopelman, Christina Kontzias, Christopher Alihosseni, et al.
Journal of Drugs in Dermatology : JDD|October 6, 2023
Cidofovir in the Management of Non-Genital Warts: A ReviewMadison K Cook, Erin M Hagen, Steven R Feldman
Journal of the American Academy of Dermatology|July 26, 2002
Off-label prescribing in the treatment of dermatologic diseaseJoel H Sugarman, Alan B Fleischer, Steven R Feldman
The Journal of Dermatological Treatment|October 28, 2022
Real-world outcomes following switching from anti-TNF reference products to biosimilars for the treatment of psoriasisRachel C Ruda, Katherine A Kelly, Steven R Feldman
Pageof 130

Showing results (371-380 of 1,293) with videos related to

Sort By:
Pageof 130
Cureus|February 27, 2023
Treatment Adherence in Dermatology During the COVID-19 Pandemic: A ReviewSarah G Bridgeman, Patrick O Perche, Steven R Feldman
Archives of Dermatological Research|January 4, 2025
Bridging the gap in early diagnosis of hidradenitis suppurativaNatalia V Chalupczak, Katie K Lovell, Steven R Feldman
Expert Review of Clinical Immunology|June 22, 2016
Current status and future prospects for biologic treatments of psoriasisAbigail Cline, Dane Hill, Robin Lewallen, et al.
The Journal of Dermatological Treatment|June 9, 2024
Racial differences in access to psoriasis biologicsShirley P Parraga, Alan B Fleischer, Steven R Feldman
The Journal of Dermatological Treatment|July 23, 2024
Utilizing artificial intelligence technology with emotional intelligence in clinical office visitsRobin C Yi, Hannah Y Gantz, Steven R Feldman
The Journal of Dermatological Treatment|October 20, 2021
The relative weak way and the absolute strong way to communicate risk informationPatrick O Perche, Madison K Cook, Steven R Feldman
Expert Opinion on Drug Metabolism & Toxicology|September 11, 2023
JAK1 inhibitors for the treatment of atopic dermatitis: a focus on pharmacokinetic considerationsHannah Kopelman, Christina Kontzias, Christopher Alihosseni, et al.
Journal of Drugs in Dermatology : JDD|October 6, 2023
Cidofovir in the Management of Non-Genital Warts: A ReviewMadison K Cook, Erin M Hagen, Steven R Feldman
Journal of the American Academy of Dermatology|July 26, 2002
Off-label prescribing in the treatment of dermatologic diseaseJoel H Sugarman, Alan B Fleischer, Steven R Feldman
The Journal of Dermatological Treatment|October 28, 2022
Real-world outcomes following switching from anti-TNF reference products to biosimilars for the treatment of psoriasisRachel C Ruda, Katherine A Kelly, Steven R Feldman
Pageof 130